PPARA and acute kidney injury: Formononetin protects against cisplatin-induced AKI by activating the PPARα/Nrf2/HO 1/NQO1 pathway, promoting renal tubular cell proliferation, and inhibiting apoptosis following cisplatin-induced AKI [27].